EUVIMEDEUVIMED entdecken
Open Access

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study

Minkwan Kim iD, Minkook Son iD, Sang Yi Moon iD, Yang Hyun Baek iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Minkwan Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital Yonsei University College of Medicine Yongin Gyeonggi-do Republic …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Alcohol Drinking, Fatty Liver, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The recent reclassification of steatotic liver disease into metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction‐associated alcohol‐related liver disease has highlighted their potential cardiovascular implications. This study aimed to investigate the impact of MASLD and metabolic dysfunction‐associated alcohol‐related liver disease on the risk of newly diagnosed atrial fibrillation (AF).

Methods

Data from 362 285 participants who underwent a health screening in 2009 to 2010, sourced from the Korean National Health Insurance database, were identified, and we retrospectively analyzed their data through 2019. Excluding those with other liver diseases and heavy alcoholics, 206 455 participants with a fatty liver index were included. The primary outcome was newly diagnosed AF; associated conditions, such as ischemic stroke and heart failure, were also investigated. Participants were classified into 4 groups based on their steatotic liver disease status and alcohol consumption levels.

Results

Over a median follow‐up of 9.6 years, 5335 participants were newly diagnosed with AF (2.74 per 1000 person‐years). The risk of AF was significantly higher in patients with MASLD who did not consume alcohol (adjusted hazard ratio [aHR], 1.32 [95% CI, 1.23–1.41]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAlcohol DrinkingFatty LiverLiver Diseases, AlcoholicHumansMaleFemaleMiddle AgedRepublic of KoreaRetrospective StudiesRisk AssessmentRisk FactorsAgedIncidenceAdultDatabases, Factual

Stichwörter der Autor:innen

alcohol intakeatrial fibrillationmetabolic dysfunctionnonalcoholic fatty liver diseasesteatotic liver disease

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital Yonsei University College of Medicine Yongin Gyeonggi-do Republic of Korea.
  • Department of Physiology Dong-A University College of Medicine Busan Republic of Korea.
  • Department of Data Sciences Convergence Dong-A University Interdisciplinary Program Busan Republic of Korea.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine Dong-A University College of Medicine Busan Republic of Korea.

ORCID-Profile: Minkwan Kim, Minkook Son, Sang Yi Moon, Yang Hyun Baek

Zitieren

APA

Kim, M., Son, M., Moon, S. Y., & Baek, Y. H. (2025). Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042003

Vancouver

Kim M, Son M, Moon SY, Baek YH. Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042003

BibTeX
@article{Kim2025,
  author = {Kim, Minkwan and Son, Minkook and Moon, Sang Yi and Baek, Yang Hyun},
  title = {Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042003}
}
Kostenlos starten →